Iberogast gets warnings after Bayer concession

Bayer Consumer Health has after a decade long stalemate with the German Federal Institute for Drugs and Medical Devices, BfArM, conceded to add warnings regarding possible liver damage to the patient information leaflet of its Iberogast gastrointestinal herbal medicine.